CV9201: Interim Phase I/IIa data

Interim data from an ongoing, open-label, Swiss and German Phase I/IIa trial in 16 evaluable stage IIIb/IV NSCLC patients who responded to or stabilized after first-line chemoradiotherapy showed that ...